Urinary Antiseptics and Quinolones

Download as pdf or txt
Download as pdf or txt
You are on page 1of 25

Urinary Antiseptics & Quinolones

Dr. Aliena Edun, BPharm, M.D.


Introduction
• Urinary tract infection (UTI) is an infection caused by pathogenic
microorganisms of one or more structures of the urinary tract.
• Common UTIs:
Cystitis—inflammation of the bladder
Urethritis—inflammation of the urethra
Prostatitis—inflammation of the prostate gland
Pyelonephritis—inflammation of the kidney and renal pelvis
• Clinical manifestations of UTIs: urgency, frequency, burning and pain on
urination (dysuria), and pain caused by spasm in the region of the bladder and
the suprapubic area.
• Some drugs used in the treatment of UTIs do not belong to the antibiotic or
sulfonamide groups of drugs.
Classification of Drugs Used To Treat UTIs
1) Urinary Antiseptics:
• Nitrofurantoin (Furadantin)
• Fosfomycin (Monurol)
• Methenamine mandelate (Mandelamine)
2) Quinolones
3) Penicillins
4) Cephalosporins
5) Sulphonamides & Trimethoprim ( Co-Trimoxazole)
Urinary Antiseptics:

Urinary antiseptics are the antimicrobial drugs that are excreted mainly in the
urine and perform it antiseptic action in the bladder.
These drugs have no action on the body system.
These drugs may be given before examination or surgery on the urinary tract or
to treat UTI.

Action:
Urinary Antiseptic are concentrated in the Kidney tubules which are mainly
useful in lower urinary tract only.
Nitrofurantoin (Furadantin)
• M.O.A: Inactivates or alters bacterial ribosomal proteins and other macromolecules that may
interfere with metabolism and cell wall synthesis.

• An agent that is both bacteriostatic and bactericidal (at high doses against gram positive and
gram negative bacteria ( except Proteus and pseudomonas).

• It is metabolized and excreted so rapidly that no systemic antibacterial action is achieved.

• The drug is excreted into the urine by both glomerular filtration and tubular secretion.

• Hence, Nitrofurantoin is contraindicated in patients with significant renal insufficiency.


Nitrofurantoin (Furadantin)
• Nitrofurantoin antagonizes the action of Nalidixic Acid.

• Side Effects: Anorexia, nausea, vomiting, brown discoloration of the urine, and
hypersensitivity reactions.

• Neuropathies and hemolytic anemia occur in patients with glucose-6-phosphate


dehydrogenase deficiency.
Fosfomycin (Monurol)
• Fosfomycin is used for UTIs that are caused by susceptible microorganisms.

• M.O.A: Blocks bacterial cell wall synthesis by inactivating enolpyruvyl


transferase; also reduces bacterial adherence to uroepithelial cells
(Bateriocidal)

• Side Effects: headache, dizziness, nausea, abdominal cramps, and vaginitis.


Methenamine mandelate (Mandelamine)
• M.O.A: Methenamine and Methenamine salts break down and form ammonia
and formaldehyde, which are bactericidal.
• These drugs are used for UTIs that are caused by susceptible microorganisms.
• This drug do not exert any antimicrobial action in the blood and body tissue and
kidneys.

• Side Effect: Gastrointestinal disturbances such as anorexia, nausea, vomiting,


stomatitis, and cramps.

• The drug is used cautiously in patients with renal or hepatic impairment or gout
(Crystalluria).
Quinolones
Quinolones
• M.O.A: Quinolones block bacterial DNA synthesis by inhibiting bacterial topoisomerase II
(DNA gyrase) and topoisomerase IV.

• In gram negative bacteria, DNA gyrase (Topoisomerase II) is the primary target.

• In gram positive bacteria, Topoisomerase IV is the primary target (newer quinolones).

• Dual MOA:
1. Inhibition of bacterial DNA Gyrase (Topoisomerase II)
a) Formation of quinolone-DNA-Gyrase complex
b) Induced cleavage of DNA

2. Inhibition of bacterial Topoisomerase IV


c) Mechanism poorly understood
Quinolones

• DNA Gyrase comprises bacterial DNA into supercoils 🡪 Inhibition of DNA


gyrase leads to the unwinding of the supercoils which leads to cell death.

• Inhibition of topoisomerase IV is blocked by Flouroquionlones which is


required by bacteria for cell division.

• They are primarily used in the treatment of susceptible microorganisms in


lower respiratory infections, infections of the skin, urinary tract infections, and
sexually transmitted diseases.
Mechanism of Action
Classification of Quinolones
• First Generation: Nalidixic Acid QUINOLONE

• Second Generation:
• Ciprofloxacin
• Norfloxacin
• Ofloxacin
• Enoxacin
• Lomefloxacin

• Third Generation:
• Gatifoxacin FLUOROQUINOLONES
• Levofloxacin
• Moxifloxacin
• Sparfloxacin

• Fourth Generation:
• Trovafloxacin
Quinolones
Agents Trade Name Availability
Ciprofloxacin Cipro® PO/IV/GUTT/Eye
oint./Ear drop
Ofloxacin Floxin® PO/IV
Norfloxacin Noroxin® PO
Enoxacin Penetrex® PO

Lomefloxacin Maxaquin® PO
Levofloxacin Levaquin® PO/IV/GUTT
Sparfloxacin Zagam® PO
Moxifloxacin Avelox®, PO/IV/GUTT
Vigamox®
Nalidixic Acid
• Non-fluorinated quinolone.

• Effective against → gram (-)/gram(+) .

• 1st quinolone with antibacterial activity 🡪 Parent drug

• Nalidixic Acid does not achieve systemic antibacterial levels therefore usage is
restricted to uncomplicated UTIs.
Fluoroquinolones
•First fluorinated quinolone – Norfloxacin.

•Newer fluorinated quinolones offer greater potency & broader


spectrum of antimicrobial activity. (3rd and 4th Generation)

•Bactericidal

•Exhibit concentration dependent killing


Pharmacokinetics:
Quinolone (1st generation):
Highly protein bound
Mostly used in UTIs
Fluoroquinolones (2nd, 3rd and 4th generation):
Modified 1st generation quinolone
Not highly protein bound
Wide distribution to urine and other tissues; limited CSF penetration.
Newer 3rd and 4th generation FQ’s have very good activity against
gram-positive organisms.
Norfloxacin 🡪 35% to 70% is orally absorbed
All other Fluoroquinolones 🡪 80% to 99%
Pharmacokinetics:
Well distributed into body tissues 🡪 bones, urine (except Moxifloxacin),
Kidneys, and Prostatic tissue (but not Prostatic fluid.

Concentrations in the lungs exceed those in serum.

Penetration into cerebrospinal fluid is relatively low except for Ofloxacin.

Most fluoroquinolones are excreted renally. Therefore, dosage adjustments are


needed in renal dysfunction.

Moxifloxacin is excreted primarily by the liver 🡪 doesn’t require renal dosing


Flouroquinolones: Spectrum of Activity
• Gram-positive (Fair)
• Moderate activity against Staphylococci (MRSA/MRSE)
• Ofloxacin, Levofloxacin & Sparfloxacin has best in vitro activity against S.
aureus
• Poor to moderate activity against streptococci and enterococci
• Useful in uncomplicated enterococcal UTIs

• Gram-negative (Excellent)
• Ciprofloxacin most potent against P. aeruginosa, however there is recent
development of resistance.
• Excellent activity against Enterobacteriaceae.
• Used in gram negative osteomyelitis, bacteremia, gastroenteritis & UTIs
Flouroquinolones: Spectrum of Activity
• Anaerobes
• Only Moxifloxacin has coverage against Anaerobes

• Atypical
• Levofloxacin & Sparfloxacin active against Chlamydia and Mycoplasma
pneumoniae

• Other pathogens
• Mycobacteria: M. avium complex (ciprofloxacin), M. tuberculosis MDRTB
(Ofloxacin)
• STD pathogens: C. trachomatis (Ofloxacin), N. gonorrhoeae (many as
single dose)
• Enteric pathogen: E. coli, Campylobacter, Salmonella, Shigella
Flouroquinolones: Spectrum of Activity
Ciprofloxacin
• Good gram-negative coverage

• N. gonorrhea, H. influenzae

• UTI, Traveler’s diarrhea caused by E. coli and Typhoid fever caused by Salmonella Typhi

• Best activity against P. aeruginosa and is commonly used in Cystic Fibrosis

Levofloxacin
• L-enantiomer of Ofloxacin

• Better gram-positive coverage (mainly Streptococcus) than Ciprofloxacin

• Used for LRTI

Moxifloxacin
• Quite broad-spectrum

• Activity against Strep/Staph plus gram-negatives


• Anaerobic coverage
• Minimal to no Anti-pseudomonal activity
Clinical uses of Fluoroquinolones:
Disease Recommendations
RESPIRATORY TRACT INFECTIONS/ENT
Pharyngitis, otitis media Not appropriate
Necrotizing otitis Ciprofloxacin for Pseudomonas aeruginosa
Sinusitis Third-generation fluoroquinolone
Community-acquired pneumonia Third-generation fluoroquinolone
Hospital-acquired pneumonia Ciprofloxacin, for susceptible gram-negative
pathogens
URINARY TRACT INFECTIONS
Cystitis, uncomplicated All effective (second generation most appropriate)

Pyelonephritis All effective (second generation most appropriate)


Prostatitis All effective
SKIN STRUCTURE INFECTIONS
Primary cellulitis Not appropriate as first line therapy
Anaerobic soft-tissue infections Not appropriate
Clinical uses of Fluoroquinolones:
Disease Recommendations
OSTEOMYELITIS
Gram-negative bacterial infections Ciprofloxacin
BACTERIAL DIARRHEAL DISEASES Ciprofloxacin used most commonly; all considered
likely to be effective
SEXUALLY TRANSMITTED DISEASES
Gonorrhea Resistance testing required
Chlamydia Ofloxacin, levofloxacin
Chancroid All likely to be effective
Mycoplasma Ofloxacin, levofloxacin
Syphilis Not appropriate
MYCOBACTERIAL DISEASES
Disseminated M. avium complex Ciprofloxacin, ofloxacin as fourth agent if needed
M. tuberculosis Ofloxacin, levofloxacin for drug-resistance or
intolerance to first-line agents
Adverse Effects:
1.GI Disturbances (< 4%): Vomiting, Nausea, Diarrhea.
2. CNS disturbances (< 3%) : Insomnia, Confusion, Convulsions, Dizziness.
(Enoxacin)
3. Nephrotoxicity → Crystalluria in patients receiving high dose, Interstitial
Nephritis
4. Photosensitivity (< 2-4%) - Sparfloxacin--sunlight or artificial UV light
5. Articular Cartilage Erosion 🡪 Damage in growing cartilage (Adolescent
Arthropathy.
• Contraindicated in pregnancy, lactation and in children under 18 years.
6. Tendonitis or Tendon rupture
7. Prolongation of the QT interval 🡪 Arrhythmias
8. Hypoglycemia and hyperglycemia
Drug Interaction
1. Antacid containing Aluminium & Magnesium/Sucralfate/Dietary supplements
containing Iron or Zinc/Calcium and other divalent and multivalent cations =
Decreased absorption of Fluoroquinolones

2. Fluoroquinolones + Theophylline/Caffeine/Warfarin/Cyclosporine = Increased


Plasma Concentration of those drugs
• Cytochrome P 450:
Enoxacin>Ciprofloxacin>Ofloxacin>Lomefloxacin
• Theophylline/caffeine- no interaction with Norfloxacin, Ofloxacin,
Lomefloxacin and Fleroxacin.
• Enoxacin- most potent effect on theophylline metabolism (~60% reduction)
3. NSAIDS- possibility increases CNS excitation 🡪 Seizures

You might also like